| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.4 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.4 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.071 | 0.4 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |